AAAAAA

   
Results: 1-3 |
Results: 3

Authors: ZAUCHA JM KNOPINSKAPOSLUSZNY W LEWANDOWSKI K HALABURDA K BIENIASZEWSKA M HELLMANN A
Citation: Jm. Zaucha et al., ALLOGENEIC PBSCT - IS ACUTE GVHD RISK INCREASED IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA (CML), Bone marrow transplantation, 21, 1998, pp. 40-40

Authors: BIENIASZAWSKA M KNOPINSKAPOSLUSZNY W ZAUCHA JM HALABURDA K HELLMANN A
Citation: M. Bieniaszawska et al., THE LONG-TERM SAFETY OF THE PBSC MOBILIZATION IN HEALTHY DONORS, Bone marrow transplantation, 21, 1998, pp. 156-156

Authors: HALABURDA K GRYCKIEWICZ R PAWELCZYK T HELLMANN A
Citation: K. Halaburda et al., THE USE OF INTRAVENOUS AND ORAL GANCICLOVIR COMBINATION IN PREEMPTIVETREATMENT OF CMV-PCR POSITIVE PATIENTS AFTER ALLOGENEIC HEMATOPOIETICSTEM-CELL TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 492-492
Risultati: 1-3 |